Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387357082> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4387357082 abstract "Aim The study aimed to estimate the cost‐effectiveness of CYP2C19 genotype‐guided antiplatelet therapy, cilostazol, and ticagrelor as an alternative to clopidogrel. Methods A 90‐day decision tree and 30‐year Markov model were employed to assess the costs and quality‐adjusted life years (QALYs) of personalized antiplatelet therapy for patients with minor ischemic stroke and high‐risk transient ischemic attack, compared to the conventional antiplatelet therapy in the Chinese healthcare system. The primary outcome was the incremental cost‐effectiveness ratio (ICER). The data sources included clinical trials, published literature, official documents, and local prices. One‐way sensitivity analysis and probabilistic sensitivity analysis were performed to confirm the robustness of the findings. Results The base‐case analysis indicated that the CYP2C19 genotype‐guided antiplatelet strategy, cilostazol group and ticagrelor group, yielding an ICER of 3327.40 US dollars (USD)/QALY and 3426.92 USD/QALY, respectively, which were less than threshold. The one‐way sensitivity analysis presented the results were robust, where the most sensitive parameter was the disability distribution in the modified Rankin Scale 3‐5. The probabilistic analysis showed that the CYP2C19 genotype‐guided antiplatelet therapy either with cilostazol or with ticagrelor was 100% cost‐effective under the willingness‐to‐pay threshold. Conclusion CYP2C19 genotype‐guided antiplatelet therapy, cilostazol, and ticagrelor as an alternative to clopidogrel, appeared to be more cost‐effective than conventional antiplatelet therapy for acute minor ischemic stroke and high‐risk transient ischemic attack patients over 30 years in China." @default.
- W4387357082 created "2023-10-06" @default.
- W4387357082 creator A5019399494 @default.
- W4387357082 creator A5029796793 @default.
- W4387357082 creator A5045167784 @default.
- W4387357082 creator A5050398965 @default.
- W4387357082 creator A5065043814 @default.
- W4387357082 date "2023-10-05" @default.
- W4387357082 modified "2023-10-06" @default.
- W4387357082 title "Cost‐effectiveness Analysis of <i>CYP2C19</i> Genotype‐guided Antiplatelet Therapy for Patients with Acute Minor Ischemic Stroke and High‐risk Transient Ischemic Attack in China" @default.
- W4387357082 doi "https://doi.org/10.1111/bcp.15921" @default.
- W4387357082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37795861" @default.
- W4387357082 hasPublicationYear "2023" @default.
- W4387357082 type Work @default.
- W4387357082 citedByCount "0" @default.
- W4387357082 crossrefType "journal-article" @default.
- W4387357082 hasAuthorship W4387357082A5019399494 @default.
- W4387357082 hasAuthorship W4387357082A5029796793 @default.
- W4387357082 hasAuthorship W4387357082A5045167784 @default.
- W4387357082 hasAuthorship W4387357082A5050398965 @default.
- W4387357082 hasAuthorship W4387357082A5065043814 @default.
- W4387357082 hasConcept C112930515 @default.
- W4387357082 hasConcept C126322002 @default.
- W4387357082 hasConcept C127413603 @default.
- W4387357082 hasConcept C140840227 @default.
- W4387357082 hasConcept C164705383 @default.
- W4387357082 hasConcept C2777628954 @default.
- W4387357082 hasConcept C2777849778 @default.
- W4387357082 hasConcept C2779820409 @default.
- W4387357082 hasConcept C2780007028 @default.
- W4387357082 hasConcept C2780645631 @default.
- W4387357082 hasConcept C2780890252 @default.
- W4387357082 hasConcept C3019080777 @default.
- W4387357082 hasConcept C3020581612 @default.
- W4387357082 hasConcept C526171541 @default.
- W4387357082 hasConcept C62231903 @default.
- W4387357082 hasConcept C64332521 @default.
- W4387357082 hasConcept C71924100 @default.
- W4387357082 hasConcept C78519656 @default.
- W4387357082 hasConceptScore W4387357082C112930515 @default.
- W4387357082 hasConceptScore W4387357082C126322002 @default.
- W4387357082 hasConceptScore W4387357082C127413603 @default.
- W4387357082 hasConceptScore W4387357082C140840227 @default.
- W4387357082 hasConceptScore W4387357082C164705383 @default.
- W4387357082 hasConceptScore W4387357082C2777628954 @default.
- W4387357082 hasConceptScore W4387357082C2777849778 @default.
- W4387357082 hasConceptScore W4387357082C2779820409 @default.
- W4387357082 hasConceptScore W4387357082C2780007028 @default.
- W4387357082 hasConceptScore W4387357082C2780645631 @default.
- W4387357082 hasConceptScore W4387357082C2780890252 @default.
- W4387357082 hasConceptScore W4387357082C3019080777 @default.
- W4387357082 hasConceptScore W4387357082C3020581612 @default.
- W4387357082 hasConceptScore W4387357082C526171541 @default.
- W4387357082 hasConceptScore W4387357082C62231903 @default.
- W4387357082 hasConceptScore W4387357082C64332521 @default.
- W4387357082 hasConceptScore W4387357082C71924100 @default.
- W4387357082 hasConceptScore W4387357082C78519656 @default.
- W4387357082 hasLocation W43873570821 @default.
- W4387357082 hasLocation W43873570822 @default.
- W4387357082 hasOpenAccess W4387357082 @default.
- W4387357082 hasPrimaryLocation W43873570821 @default.
- W4387357082 hasRelatedWork W2018431503 @default.
- W4387357082 hasRelatedWork W2140255896 @default.
- W4387357082 hasRelatedWork W2146893505 @default.
- W4387357082 hasRelatedWork W2334664526 @default.
- W4387357082 hasRelatedWork W2888486536 @default.
- W4387357082 hasRelatedWork W2990176811 @default.
- W4387357082 hasRelatedWork W4284680749 @default.
- W4387357082 hasRelatedWork W4300958060 @default.
- W4387357082 hasRelatedWork W807291017 @default.
- W4387357082 hasRelatedWork W2620558428 @default.
- W4387357082 isParatext "false" @default.
- W4387357082 isRetracted "false" @default.
- W4387357082 workType "article" @default.